Thyroid Nodule Diagnosed as Parathyroid Adenoma: Rethinking Cytology Findings

Abstract

Precise diagnosis of thyroid nodules is important in planning proper management and treatment. Cytological examination through fine-needle aspiration (FNA) tends to classify thyroid nodules as benign, malignant, or indeterminate. Indeterminate lesions with low malignancy risk present a diagnostic challenge since they could be benign thyroid nodules, low-grade malignancies, or unsuspected pathology like parathyroid adenoma. This article reports a case of a thyroid nodule initially diagnosed as an indeterminate lesion with low malignant potential but finally diagnosed as a parathyroid adenoma. We discuss the difficulties in distinguishing thyroid and parathyroid lesions, the contribution of cytology and imaging modalities, and the implications for clinical practice.

Introduction

Thyroid nodules are not uncommon, with a prevalence of as much as 65% in the general population when found on ultrasonography. Most thyroid nodules are benign, although a few are malignant. Fine-needle aspiration (FNA) biopsy is a standard tool for evaluating thyroid nodules and is an important part of risk stratification. Some nodules, however, have indeterminate characteristics, complicating management. Some of these indeterminate nodules might indeed be parathyroid lesions, such as parathyroid adenomas, which can masquerade thyroid pathology on radiological and cytological assessment. It is crucial to differentiate thyroid from parathyroid lesions, as their implications and treatment protocols are vastly different.

Thyroid Nodule Evaluation and the Bethesda System

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) classifies FNA findings into six diagnostic categories: non-diagnostic, benign, atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS), follicular neoplasm/suspicious for follicular neoplasm (FN/SFN), suspicious for malignancy, and malignant. Indeterminate thyroid nodules are usually classified in the AUS/FLUS or FN/SFN categories, with malignancy risk ranging from 5% to 30%.

Parathyroid Adenoma Mimicking Thyroid Nodules

Parathyroid adenomas are benign tumors of the parathyroid glands that cause primary hyperparathyroidism (PHPT). These lesions can be mistaken for thyroid nodules due to their anatomical proximity, overlapping sonographic features, and similar cytological appearances. While parathyroid adenomas are usually identified through elevated serum calcium and parathyroid hormone (PTH) levels, some cases present without overt biochemical abnormalities, leading to misclassification as thyroid nodules.

Case Presentation: A Diagnostic Dilemma

A 54-year-old woman presented with a thyroid nodule incidentally discovered during a routine ultrasound evaluation for neck discomfort. The nodule measured 1.8 cm, was hypoechoic with minimal vascularity, and lacked calcifications. FNA cytology was reported as an indeterminate follicular lesion with a low risk of malignancy. Molecular testing did not reveal high-risk mutations. Given the low-risk classification, the patient was initially advised on periodic follow-up. However, a subsequent increase in serum calcium levels prompted further investigation. A dedicated sestamibi scan and PTH assay confirmed the presence of a parathyroid adenoma, leading to surgical excision.

Differentiating Thyroid and Parathyroid Lesions: Diagnostic Tools

Distinguishing between thyroid nodules and parathyroid adenomas requires a combination of cytological, biochemical, and imaging assessments. Key diagnostic modalities include:

1. Ultrasonography: Parathyroid adenomas often appear as hypoechoic, well-defined lesions posterior to the thyroid gland. However, in ectopic locations or cases where adenomas about the thyroid, differentiation becomes difficult.

2. Fine-Needle Aspiration (FNA) Cytology: Cytological smears of parathyroid adenomas can resemble follicular-patterned thyroid lesions, making misdiagnosis possible. The presence of oncocytic or chief cells can be misleading.

3. Parathyroid Hormone (PTH) Assay in FNA Washout: Measuring PTH levels in the needle washout fluid can confirm parathyroid origin. High PTH levels strongly suggest a parathyroid adenoma rather than a thyroid lesion.

4. Molecular Testing: Genetic markers like RET/PTC and BRAF mutations are typically associated with thyroid malignancies, while HRPT2 mutations may indicate parathyroid pathology.

5. Sestamibi Scan and SPECT Imaging: Tc-99m sestamibi scintigraphy is highly sensitive for detecting hyperfunctioning parathyroid adenomas, particularly in cases where sonographic findings are inconclusive.

Clinical Implications and Management

The misclassification of a parathyroid adenoma as a thyroid nodule can lead to inappropriate management decisions. In cases of indeterminate thyroid nodules with low-risk cytology, additional biochemical and imaging tests should be considered to exclude a parathyroid etiology. Key clinical implications include:

1. Avoiding Unnecessary Thyroid Surgery: Patients with parathyroid adenomas misdiagnosed as thyroid nodules may undergo unnecessary lobectomy or thyroidectomy, leading to unwarranted surgical risks and complications.

2. Optimizing Surgical Approach: Accurate preoperative identification of a parathyroid adenoma allows for minimally invasive parathyroidectomy instead of more extensive thyroid surgery.

3. Improving Patient Outcomes: Proper diagnosis ensures appropriate management of primary hyperparathyroidism, reducing long-term complications such as osteoporosis, kidney stones, and cardiovascular issues.

Conclusion

This case illustrates the need for a careful diagnostic strategy in the assessment of thyroid nodules, particularly those classified as indeterminate with low malignancy risk. Since parathyroid adenomas may be mistaken for thyroid nodules, the incorporation of biochemical studies, PTH washout tests, and newer imaging modalities into standard evaluation can improve the accuracy of diagnosis. A multidisciplinary evaluation by endocrinologists, radiologists, and pathologists is essential in differentiating thyroid and parathyroid lesions to achieve the best possible patient care and treatment results.

Read more such content on @ Hidoc Dr | Medical Learning App for Doctors